Comparative effectiveness of GDMT in the prevention of HF morbidity and death among patients with HFrEF in a U.S. database

Back

ESC Professional Premium Access

Comparative effectiveness of GDMT in the prevention of HF morbidity and death among patients with HFrEF in a U.S. database

Session: Epidemiology and outcomes

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor L. Bash (Whitehouse Station, US) Doctor A. Stevenson (Chatham, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speakers

Doctor Lori Bash

Merck and Company, Inc., Whitehouse Station (United States of America)

0 follower

Doctor Andra Stevenson

Chatham (United States of America)

2 presentations

0 follower

7 more presentations in this session

Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum

Speaker: Doctor G. Heitzinger (Vienna, AT)

The prognostic association of atrial fibrillation on heart failure hospitalizations after acute myocardial infarction

Speaker: Doctor A. Achanta (Boston, US)

Incorporating hypochloremia provides additive prognostic information in hospitalized patients with heart failure

Speaker: Doctor K. Misumi (Utsunomiya, JP)

Change in incidence of ischemic stroke and mortality among patients with atrial fibrillation over a period of 30 years, a nationwide, register-based cohort study

Speaker: Doctor C. Basic (Gothenburg, SE)

Long-term prognostic significance modified body mass index in patients with decompensated acute heart failure: Insight from the OPAR study

Speaker: Doctor Y. Chang (Osaka, JP)

Access the full session

Epidemiology and outcomes

Speakers: Doctor L. Bash, Doctor A. Stevenson, Doctor G. Heitzinger, Doctor A. Achanta, Doctor K. Misumi...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources